Presentations of children to emergency departments across Europe and the COVID-19 pandemic: A multinational observational study.
Journal
PLoS medicine
ISSN: 1549-1676
Titre abrégé: PLoS Med
Pays: United States
ID NLM: 101231360
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
received:
18
03
2022
accepted:
28
07
2022
revised:
12
09
2022
pubmed:
27
8
2022
medline:
15
9
2022
entrez:
26
8
2022
Statut:
epublish
Résumé
During the initial phase of the Coronavirus Disease 2019 (COVID-19) pandemic, reduced numbers of acutely ill or injured children presented to emergency departments (EDs). Concerns were raised about the potential for delayed and more severe presentations and an increase in diagnoses such as diabetic ketoacidosis and mental health issues. This multinational observational study aimed to study the number of children presenting to EDs across Europe during the early COVID-19 pandemic and factors influencing this and to investigate changes in severity of illness and diagnoses. Routine health data were extracted retrospectively from electronic patient records of children aged 18 years and under, presenting to 38 EDs in 16 European countries for the period January 2018 to May 2020, using predefined and standardized data domains. Observed and predicted numbers of ED attendances were calculated for the period February 2020 to May 2020. Poisson models and incidence rate ratios (IRRs), using predicted counts for each site as offset to adjust for case-mix differences, were used to compare age groups, diagnoses, and outcomes. Reductions in pediatric ED attendances, hospital admissions, and high triage urgencies were seen in all participating sites. ED attendances were relatively higher in countries with lower SARS-CoV-2 prevalence (IRR 2.26, 95% CI 1.90 to 2.70, p < 0.001) and in children aged <12 months (12 to <24 months IRR 0.86, 95% CI 0.84 to 0.89; 2 to <5 years IRR 0.80, 95% CI 0.78 to 0.82; 5 to <12 years IRR 0.68, 95% CI 0.67 to 0.70; 12 to 18 years IRR 0.72, 95% CI 0.70 to 0.74; versus age <12 months as reference group, p < 0.001). The lowering of pediatric intensive care admissions was not as great as that of general admissions (IRR 1.30, 95% CI 1.16 to 1.45, p < 0.001). Lower triage urgencies were reduced more than higher triage urgencies (urgent triage IRR 1.10, 95% CI 1.08 to 1.12; emergent and very urgent triage IRR 1.53, 95% CI 1.49 to 1.57; versus nonurgent triage category, p < 0.001). Reductions were highest and sustained throughout the study period for children with communicable infectious diseases. The main limitation was the retrospective nature of the study, using routine clinical data from a wide range of European hospitals and health systems. Reductions in ED attendances were seen across Europe during the first COVID-19 lockdown period. More severely ill children continued to attend hospital more frequently compared to those with minor injuries and illnesses, although absolute numbers fell. ISRCTN91495258 https://www.isrctn.com/ISRCTN91495258.
Sections du résumé
BACKGROUND
During the initial phase of the Coronavirus Disease 2019 (COVID-19) pandemic, reduced numbers of acutely ill or injured children presented to emergency departments (EDs). Concerns were raised about the potential for delayed and more severe presentations and an increase in diagnoses such as diabetic ketoacidosis and mental health issues. This multinational observational study aimed to study the number of children presenting to EDs across Europe during the early COVID-19 pandemic and factors influencing this and to investigate changes in severity of illness and diagnoses.
METHODS AND FINDINGS
Routine health data were extracted retrospectively from electronic patient records of children aged 18 years and under, presenting to 38 EDs in 16 European countries for the period January 2018 to May 2020, using predefined and standardized data domains. Observed and predicted numbers of ED attendances were calculated for the period February 2020 to May 2020. Poisson models and incidence rate ratios (IRRs), using predicted counts for each site as offset to adjust for case-mix differences, were used to compare age groups, diagnoses, and outcomes. Reductions in pediatric ED attendances, hospital admissions, and high triage urgencies were seen in all participating sites. ED attendances were relatively higher in countries with lower SARS-CoV-2 prevalence (IRR 2.26, 95% CI 1.90 to 2.70, p < 0.001) and in children aged <12 months (12 to <24 months IRR 0.86, 95% CI 0.84 to 0.89; 2 to <5 years IRR 0.80, 95% CI 0.78 to 0.82; 5 to <12 years IRR 0.68, 95% CI 0.67 to 0.70; 12 to 18 years IRR 0.72, 95% CI 0.70 to 0.74; versus age <12 months as reference group, p < 0.001). The lowering of pediatric intensive care admissions was not as great as that of general admissions (IRR 1.30, 95% CI 1.16 to 1.45, p < 0.001). Lower triage urgencies were reduced more than higher triage urgencies (urgent triage IRR 1.10, 95% CI 1.08 to 1.12; emergent and very urgent triage IRR 1.53, 95% CI 1.49 to 1.57; versus nonurgent triage category, p < 0.001). Reductions were highest and sustained throughout the study period for children with communicable infectious diseases. The main limitation was the retrospective nature of the study, using routine clinical data from a wide range of European hospitals and health systems.
CONCLUSIONS
Reductions in ED attendances were seen across Europe during the first COVID-19 lockdown period. More severely ill children continued to attend hospital more frequently compared to those with minor injuries and illnesses, although absolute numbers fell.
TRIAL REGISTRATION
ISRCTN91495258 https://www.isrctn.com/ISRCTN91495258.
Identifiants
pubmed: 36026507
doi: 10.1371/journal.pmed.1003974
pii: PMEDICINE-D-22-00899
pmc: PMC9467376
doi:
Banques de données
ISRCTN
['ISRCTN91495258']
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1003974Subventions
Organisme : Department of Health
ID : ACL-2018-021-007
Pays : United Kingdom
Commentaires et corrections
Type : ErratumIn
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
BMJ Paediatr Open. 2022 Jan;6(1):
pubmed: 36053583
Clin Infect Dis. 2013 Feb;56(4):509-16
pubmed: 23087391
BMJ Paediatr Open. 2021 Dec;5(1):
pubmed: 35413003
Lancet Child Adolesc Health. 2020 Aug;4(8):e32-e33
pubmed: 32598871
J Korean Med Sci. 2017 Oct;32(10):1576-1580
pubmed: 28875599
Clin Infect Dis. 2021 Jan 27;72(2):319-322
pubmed: 33501967
Ital J Pediatr. 2021 Jan 29;47(1):21
pubmed: 33514391
Lancet Psychiatry. 2021 May;8(5):353-354
pubmed: 33444548
Indian J Pediatr. 2021 Apr;88(4):392
pubmed: 33146879
Lancet Public Health. 2021 Feb;6(2):e124-e135
pubmed: 33444560
BMJ. 2021 Mar 10;372:n614
pubmed: 33692087
Front Endocrinol (Lausanne). 2020 Nov 13;11:596898
pubmed: 33281748
JAMA Pediatr. 2022 Apr 1;176(4):414-415
pubmed: 35072727
Arch Dis Child. 2020 Jul;105(7):704
pubmed: 32376695
Eur Child Adolesc Psychiatry. 2022 Jul;31(7):1-13
pubmed: 33677628
Intern Emerg Med. 2021 Sep;16(6):1683-1690
pubmed: 33683538
Int J Environ Res Public Health. 2020 Sep 15;17(18):
pubmed: 32942698
Diabetes Care. 2020 Nov;43(11):e172-e173
pubmed: 32826282
Eur J Pediatr. 2021 Jul;180(7):2271-2279
pubmed: 33723971
Diabetes Care. 2020 Nov;43(11):e170-e171
pubmed: 32816997
BMJ Paediatr Open. 2021 Mar 15;5(1):e000967
pubmed: 34192192
Lancet Child Adolesc Health. 2020 May;4(5):e10-e11
pubmed: 32278365
N Engl J Med. 2020 Jul 9;383(2):187-190
pubmed: 32356945
Pediatrics. 2021 Apr;147(4):
pubmed: 33361360
J Allergy Clin Immunol Pract. 2020 Nov - Dec;8(10):3378-3387.e11
pubmed: 32827728
Pediatr Emerg Care. 2021 Mar 1;37(3):185-190
pubmed: 33651763
Am J Emerg Med. 2012 Feb;30(2):275-82
pubmed: 21208765
BMJ. 2020 Aug 27;370:m3249
pubmed: 32960186
BMJ Open. 2021 Feb 5;11(2):e043024
pubmed: 33550257
BMJ. 2004 Sep 18;329(7467):660
pubmed: 15313884
N Engl J Med. 2020 Apr 23;382(17):1663-1665
pubmed: 32187458
Pediatr Emerg Care. 2021 Feb 1;37(2):123-125
pubmed: 33512891
Arch Dis Child. 2022 Feb;107(2):180-185
pubmed: 34045208
Am J Disaster Med. 2011 Jul-Aug;6(4):211-8
pubmed: 22010598
SN Compr Clin Med. 2020;2(11):1959-1969
pubmed: 32984767
Front Pediatr. 2020 Sep 18;8:521
pubmed: 33072657
Diabetes Care. 2020 Nov;43(11):2870-2872
pubmed: 32778554
BMC Pediatr. 2020 Dec 23;20(1):562
pubmed: 33353540
Diabetes Ther. 2021 May;12(5):1569-1574
pubmed: 33730335
Pediatr Emerg Care. 2021 Aug 1;37(8):427-434
pubmed: 34074990
Euro Surveill. 2009 Oct 22;14(42):
pubmed: 19883546
Pediatr Infect Dis J. 2021 Jan;40(1):e35-e36
pubmed: 33105341
BMC Infect Dis. 2011 Nov 07;11:313
pubmed: 22060843
J Pediatr Urol. 2021 Aug;17(4):479.e1-479.e6
pubmed: 33994321
Pediatr Emerg Care. 2020 Nov;36(11):551-553
pubmed: 32925702
Lancet Child Adolesc Health. 2020 Aug;4(8):634-640
pubmed: 32540024
BMJ Open. 2021 Mar 18;11(3):e047961
pubmed: 33737445
Arch Dis Child. 2021 Feb;106(2):e8
pubmed: 32586927
Emerg Med Australas. 2021 Apr;33(2):324-330
pubmed: 33078509
CJEM. 2006 Sep;8(5):323-8
pubmed: 17338843
J Adolesc Health. 2021 Oct;69(4):660-663
pubmed: 34266715
CMAJ. 2004 Nov 23;171(11):1353-8
pubmed: 15557588
J Pediatr. 2020 Aug;223:199-203.e1
pubmed: 32405091
Arch Dis Child. 2020 Aug;105(8):810-811
pubmed: 32518141
MMWR Morb Mortal Wkly Rep. 2020 Nov 13;69(45):1675-1680
pubmed: 33180751
Clin Child Psychol Psychiatry. 2021 Jan;26(1):33-38
pubmed: 33183097
Lancet Child Adolesc Health. 2020 Sep;4(9):653-661
pubmed: 32593339
J Pediatr Urol. 2021 Aug;17(4):478.e1-478.e6
pubmed: 33832873
BMJ Paediatr Open. 2021 Mar 11;5(1):e001013
pubmed: 34192195
West J Emerg Med. 2021 May 07;22(3):603-607
pubmed: 34125034
Pediatr Infect Dis J. 2004 Jul;23(7):675-7
pubmed: 15247610
Lancet Respir Med. 2020 Nov;8(11):1070-1071
pubmed: 32593314
Nat Metab. 2021 Feb;3(2):149-165
pubmed: 33536639
Ann Emerg Med. 2020 Dec;76(6):788-800
pubmed: 32419713
Eur J Pediatr Surg. 2022 Jun;32(3):268-273
pubmed: 33618382
J Formos Med Assoc. 2006 Jan;105(1):31-7
pubmed: 16440068
Am J Emerg Med. 2021 Mar;41:201-204
pubmed: 33257144
Ann Emerg Med. 2020 Nov;76(5):595-601
pubmed: 33008651
J Pediatr Urol. 2020 Dec;16(6):841.e1-841.e5
pubmed: 33223456